ArticleOpen heart2021

High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI.

Ingvild Maria Tøllefsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.